UK children with cancer could miss out on drug trials after Brexit, doctors warn

Fears youngsters could be denied access to Europe-wide tests of new medicines when Britain leaves EU amid calls for reform

Leading doctors are warning that British children with cancer could suffer if they are no longer able to join Europe-wide trials of innovative new medicines as a result of the Brexit deal.

The Institute of Cancer Research (ICR) and the Royal Marsden NHS Foundation Trust say the best hope for some children with cancer is a clinical trial where a new drug is being tested. But because of the small number of children with the same cancers, the trials have to be run in many hospitals, often across Europe.